Paolo Ciracì

Paolo Ciracì: Evidence-Based Algorithm on late-line Treatment options for mCRC

Paolo Ciracì, Oncology Resident at University Hospital of Pisa, shared an article on X:

“Our review and evidence-based algorithm on late-line treatment options for metastatic colorectal cancer patients .”

Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm.

Authors: Paolo Ciracì, et al.

Paolo Ciracì: Evidence-Based Algorithm on late-line Treatment options for mCRC

 

cancer mCRC Metastatic colorectal cancer OncoDaily Oncology Paolo Ciracì Pisa University Hospital